SCHEMBL24344762

SCHEMBL24344762

Cc1c(C(C)(C)C)oc2c1ccc1ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.54
HPGD P15428 7/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
KMT2A Q03164 3/20 0.49
ALDH1A1 P00352 6/20 0.44
MAPT P10636 5/20 0.44
MEN1 O00255 2/20 0.44
HTT P42858 3/20 0.42
PAX8 Q06710 1/20 0.42
TSHR P16473 3/20 0.42
CYP3A4 P08684 3/20 0.42
HSD17B10 Q99714 3/20 0.42
MAPK1 P28482 2/20 0.42
CASP1 P29466 1/20 0.42
RAB9A P51151 1/20 0.42
CASP7 P55210 1/20 0.42
ATM Q13315 1/20 0.42
HIF1A Q16665 1/20 0.42
CYP1A2 P05177 5/20 0.41
CYP2A6 P11509 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19916949 0.78 KDM4E (0.60) KDM4EHPGDL3MBTL1KMT2AALDH1A1
SCHEMBL22857637 0.77 MCL1 (0.50) ALDH1A1ATMCYP1A2CYP2A6SMN1; SMN2
SCHEMBL7915211 0.75 KDM4E (0.61) KDM4EHPGDL3MBTL1KMT2AALDH1A1
SCHEMBL23561582 0.73 KMT2A (0.50) KDM4EHPGDL3MBTL1KMT2AALDH1A1
SCHEMBL30154375 0.72 HPRT1 (0.57) KDM4EHPGDL3MBTL1KMT2AALDH1A1
SCHEMBL5470220 0.72 HPRT1 (0.57) KDM4EHPGDL3MBTL1KMT2AALDH1A1
SCHEMBL16282356 0.72 KMT2A (0.45) KDM4EHPGDL3MBTL1KMT2AALDH1A1
SCHEMBL8871256 0.72 ALDH1A1 (0.45) KDM4EHPGDL3MBTL1KMT2AALDH1A1
SCHEMBL22308145 0.71 TSHR (0.59) KDM4EHPGDL3MBTL1KMT2AALDH1A1
SCHEMBL11743090 0.70 KDM4E (1.00) KDM4EHPGDL3MBTL1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220085302-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220085302-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LIFR, LBR, EPOR KDM4E 1551/4885HPGD 3017/4885L3MBTL1 1033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.